Skip to content
naulon

Not checkedNot checked for notices yet.

ACUTE CORONARY SYNDROME IN MALIGNANCY PATIENTS

E. S. Luboyatnikova, D. V. Duplyakov

Российский кардиологический журнал · 2017

doi:10.15829/1560-4071-2017-3-140-144 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Acute coronary syndrome (ACS) during the time after diagnosis of oncologic disease, develops in 1,9-4,2% patients, and not seldom in intact coronary arteries. In ACS morbidity structure there is mostly non-ST elevation ACS (>85%). Specific factors for its development are thrombocytopenia, incl. the one caused by chemotherapy, and radiotherapy. Patients with active oncologic process have higher risk of death during ACS treatment than patients already “cured”. Tactics of ACS in oncology remains outside current guidelines; as such patients were not included in randomized trials. Still, some studies showed efficacy of acetylsalicylic acid, double antiplatelet therapy, percutaneous interventions. However, hemostasis system shifts, cardiotoxicity of chemotherapeutic agents, radiotherapy risks make the multidisciplinary approach necessary in management of ACS in this sort of patients.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.